Inger Birgitta Fogelberg
Geen lopende functies
Profiel
Inger Birgitta Fogelberg worked as a Director at Visionar Preclinical AB from 2000 to 2011 and as a Principal at Pharmacia AB from 1984 to 1994.
She also held a Principal position at the University of Uppsala.
Eerdere bekende functies van Inger Birgitta Fogelberg
| Bedrijven | Functie | Einde |
|---|---|---|
Visionar Preclinical AB
 Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials. | Director/Board Member | 21-11-2011 |
| Pharmacia AB | Corporate Officer/Principal | 01-01-1994 |
| University of Uppsala | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| Pharmacia AB | Health Technology |
Visionar Preclinical AB
Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials. | Commercial Services |
